Blogroll

It is unclear how the arrival of winter in the southern hemisphere will impact the novel coronavirus, the head of the World Health Organization's emergencies programme Mike Ryan said on Wednesday.

Chinese video app TikTok's practices are to be examined by an EU task force, the bloc's privacy watchdog said on Wednesday, which also warned EU police forces against using facial recognition software from U.S. company Clearview AI.

Britain's competition regulator has given itself two more months to make a final ruling on Amazon's purchase of a minority stake in online delivery group Deliveroo so it can take full account of representations from all interested parties.

The National Institutes of Health (NIH) on Wednesday launched a study to evaluate drugs prescribed to treat COVID-19, the respiratory disease caused by the new coronavirus, among children and adolescents across the United States.

Johnson & Johnson said on Wednesday it would bring forward by two months human trials of its potential COVID-19 vaccine to the second half of July, as the drugmaker rushes to develop a shot for the contagious respiratory disease.

Scientists have used human embryonic stem cells to create an embryo-like research model to help them study some of the earliest stages of human development.

Abbvie Inc said on Wednesday it is partnering with Danish biotech firm Genmab AS to jointly develop and market cancer treatments, as it looks to expand its cancer franchise.

European food ordering firm Just Eat Takeaway.com NV said on Wednesday it was in advanced talks to buy Grubhub Inc in an all-stock deal.

Jack Dorsey, the chief executive of Square Inc and Twitter Inc, said June 19, popularly known as 'Juneteenth', would be a permanent company-wide holiday in the United States to show support for racial diversity.

Ghana's Incas Diagnostics expects the country's regulator to approve its new COVID-19 antibody test by the end of July, saying its kits could help health authorities ease pandemic restrictions.

Volkswagen on Wednesday said its "first edition" ID.3 electric car will go on sale for under 40,000 euros ($45,484.00) next week, with deliveries due from September, as the German carmaker embarks on a mass production push for zero-emission cars.

Abbvie Inc said on Wednesday it is partnering with Danish biotech firm Genmab AS to jointly develop and market cancer treatments, as it looks to expand its cancer franchise.

Social network company Reddit on Wednesday named venture capital investor Michael Seibel to its board, days after co-founder and former director Alexis Ohanian resigned and called for the company to replace him with a black candidate.

Tesla Inc's chief executive Elon Musk said that it is time to bring its Semi commercial truck to "volume production", as the U.S. electric vehicle maker ramps up vehicle production after a brief virus-related shutdown.

Travelling in convoy through the Chinese city of Wuhan last September, Angela Merkel called a halt. As her party crossed a bridge over the Yangtze river, the German Chancellor wanted to hear about a grand gesture by revolutionary leader Mao Zedong.

Population-wide face mask use could push COVID-19 transmission down to controllable levels for national epidemics, and could prevent further waves of the pandemic disease when combined with lockdowns, according to a British study on Wednesday.

A Chinese vaccine against African swine fever appears to be safe in clinical trials now underway, the official Xinhua news agency said on Wednesday, a step closer to preventing one of the world's most devastating livestock diseases.

Israel's main phone company said on Wednesday it would collaborate with the country's ambulance service in replacing thousands of public phone booths with defibrillator stations.

China's internet regulator on Wednesday ordered the Sina Weibo social media platform to disable some of its features for a week, rare punishment for what it said was interference with online communication, among other things.

European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like AstraZeneca and Johnson & Johnson.